Intradermally administered TLR4 agonist GLA-SE enhances the...

Vaccine 2012 Vol. 30; Iss. 28

Intradermally administered TLR4 agonist GLA-SE enhances the capacity of human skin DCs to activate T cells and promotes emigration of Langerhans cells

Laura P. Schneider, Antoinet J. Schoonderwoerd, Magdalini Moutaftsi, Randall F. Howard, Steven G. Reed, Esther C. de Jong, Marcel B.M. Teunissen
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Year:
2012
Language:
english
DOI:
10.1016/j.vaccine.2012.04.051
File:
PDF, 1.09 MB
english, 2012
Conversion to is in progress
Conversion to is failed